The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab

by Pascal Gasser, Svetlana S. Tarchevskaya, Pascal Guntern, Daniel Brigger, Rahel Ruppli, Noemi Zbären, Silke Kleinboelting, Christoph Heusser, Theodore S. Jardetzky, Alexander Eggel
Published 2020-01-01